Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2018.06.22
2017年年度权益分派实施公告
2018.06.07
第四届监事会第十次会议决议公告
2018.06.07
第四届董事会第十四次会议决议公告
2018.06.07
关于控股子公司股权转让的公告
2018.06.07
关于深圳君圣泰生物技术有限公司的股权架构调整的公告
2018.06.07
关于开展2018年远期外汇交易情况的公告
2018.05.30
关于2017年年报问询函的回复公告
2018.05.30
关于深圳证券交易所对公司的问询函的回复
2018.05.29
关于2017年年报全文的补充公告
2018.05.17
2017年度股东大会决议公告
第一页
上一页
58
59
60
61
62
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
